Marshall Wace LLP decreased its holdings in shares of Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report) by 44.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,807 shares of the company’s stock after selling 9,635 shares during the quarter. Marshall Wace LLP owned about 0.36% of Innovator IBD 50 ETF worth $328,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in FFTY. Del Sette Capital Management LLC lifted its position in shares of Innovator IBD 50 ETF by 114.8% in the 2nd quarter. Del Sette Capital Management LLC now owns 233,088 shares of the company’s stock worth $6,473,000 after acquiring an additional 124,582 shares during the period. Great Valley Advisor Group Inc. acquired a new position in shares of Innovator IBD 50 ETF in the 2nd quarter worth approximately $1,422,000. Cowa LLC acquired a new position in shares of Innovator IBD 50 ETF in the 2nd quarter worth approximately $266,000. IronBridge Private Wealth LLC raised its holdings in shares of Innovator IBD 50 ETF by 2.5% in the 1st quarter. IronBridge Private Wealth LLC now owns 287,554 shares of the company’s stock worth $7,948,000 after buying an additional 6,999 shares in the last quarter. Finally, Hollencrest Capital Management raised its holdings in shares of Innovator IBD 50 ETF by 139.1% in the 1st quarter. Hollencrest Capital Management now owns 2,307 shares of the company’s stock worth $64,000 after buying an additional 1,342 shares in the last quarter.
Innovator IBD 50 ETF Trading Up 1.7 %
Shares of FFTY opened at $27.60 on Friday. Innovator IBD 50 ETF has a 1 year low of $20.55 and a 1 year high of $29.15. The stock has a 50 day simple moving average of $25.91 and a 200-day simple moving average of $26.86. The stock has a market cap of $89.70 million, a PE ratio of 18.67 and a beta of 1.50.
Innovator IBD 50 ETF Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Read More
- Five stocks we like better than Innovator IBD 50 ETF
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- How to Invest in Blue Chip Stocks
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Where to Find Earnings Call Transcripts
- 4 Quirky ETFs With Big Potential for Impressive Gains
Want to see what other hedge funds are holding FFTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report).
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.